- freely available
- re-usable
Molecules 2009, 14(10), 4166-4179; doi:10.3390/molecules14104166
Article
Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia Cells
1
Shenyang Pharmaceutical University, Shenyang, 110016, China
2
Mount Sinai School of Medicine, New York, NY 10029, USA
* Author to whom correspondence should be addressed.
Received: 1 September 2009; in revised form: 30 September 2009 / Accepted: 12 October 2009 / Published: 19 October 2009
Abstract: A series of novel 2-phenylaminopyrimidine (PAP) derivatives structurally related to STI-571 were designed and synthesized. The abilities of these compounds to inhibit proliferation were tested in human chronic myeloid leukemia K562 cells. (E)-3-(2-bromophenyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]acrylamide(12d) was the most effective cell growth inhibitor and was 3-fold more potent than STI-571.
Keywords: 2-Phenylaminopyrimidine (PAP) derivative; STI-571; antiproliferative activity
Article Statistics
Click here to load and display the download statistics.Cite This Article
MDPI and ACS Style
Chang, S.; Yin, S.-L.; Wang, J.; Jing, Y.-K.; Dong, J.-H. Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia Cells. Molecules 2009, 14, 4166-4179.
AMA StyleChang S, Yin S-L, Wang J, Jing Y-K, Dong J-H. Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia Cells. Molecules. 2009; 14(10):4166-4179.
Chicago/Turabian StyleChang, Sheng; Yin, Shi-Liang; Wang, Jian; Jing, Yong-Kui; Dong, Jin-Hua. 2009. "Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia Cells." Molecules 14, no. 10: 4166-4179.
Molecules
EISSN 1420-3049
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert
